Acadia Pharmaceuticals (ACAD) Amortizatization of Intangibles (2011 - 2026)

Acadia Pharmaceuticals' Amortizatization of Intangibles history runs 16 years deep, the most recent figure standing at $453000.0 for Q1 2026.

• On a quarterly basis, Amortizatization of Intangibles fell 78.59% year-over-year to $453000.0 in Q1 2026; TTM through Mar 2026 was $3.8 million, a 60.96% decrease from a year earlier, with the FY2025 full-year figure at $5.4 million, down 41.7% from the prior year.
• Amortizatization of Intangibles fell to $453000.0 in Q1 2026 per ACAD's latest filing, from $670000.0 in the prior quarter.
• Across five years, Amortizatization of Intangibles topped out at $2.8 million in Q4 2024 and bottomed at -$447000.0 in Q1 2022.
• The 5-year median for Amortizatization of Intangibles is $1.8 million (2023), against an average of $1.5 million.
• Across the five-year window, Amortizatization of Intangibles soared 1591.0% in 2023 and sank 78.59% in 2026, its largest moves.
• Year by year, Amortizatization of Intangibles stood at $2.1 million in 2022, then dropped by 15.04% to $1.8 million in 2023, then surged by 58.35% to $2.8 million in 2024, then sank by 76.22% to $670000.0 in 2025, then slumped by 32.39% to $453000.0 in 2026.
• Per Business Quant, the three latest ACAD Amortizatization of Intangibles figures stand at $453000.0 (Q1 2026), $670000.0 (Q4 2025), and $1.1 million (Q3 2025).